MENU
FULC
AS OF
Nov 13, 04:59 PM (EDT)
Price
$8.78
Change
+$0.41 (+4.90%)
Capitalization
452.43M
105 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
FULC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Fulcrum Therapeutics (FULC) Earnings Date & Reports

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

FULC is expected to report earnings to -31 cents per share on February 26

Fulcrum Therapeutics FULC Stock Earnings Reports
Q4'25
Est.
$-0.31
Q3'25
Missed
by $0.02
Q2'25
Beat
by $0.01
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.03
The last earnings report on October 29 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 347.71K shares outstanding, the current market capitalization sits at 452.43M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
FULC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FULC showed earnings on October 29, 2025. You can read more about the earnings report here.
View AI-Driven Trading for FULC
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
76
Web
https://www.fulcrumtx.com